Anadin Joint Pain 200mg Tablets

Concepts (40)

• +Angioedema (deep swelling)Contraindicated

  Hypersensitivity to ibuprofen or of any of the constituents in the product (see Section 4.4 Special Warnings and Precautions). Ibuprofen is contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory (NSAID) drugs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Pat …

  Source SmPC ↗
• +Bleeding riskContraindicated

  … cated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory (NSAID) drugs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (see secti …

  Source SmPC ↗
• +Heart conditionsContraindicated

  … gs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (see section 4.4). Use in last trimester of pregnancy (see section 4.6 Fertility, Pregnancy and Lactation).

  Source SmPC ↗
• +Stomach and gutContraindicated

  … cated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory (NSAID) drugs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (see secti …

  Source SmPC ↗
• +Liver conditionsContraindicated

  … gs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (see section 4.4). Use in last trimester of pregnancy (see section 4.6 Fertility, Pregnancy and Lactation).

  Source SmPC ↗
• +Allergy to the medicineContraindicated

  Hypersensitivity to ibuprofen or of any of the constituents in the product (see Section 4.4 Special Warnings and Precautions). Ibuprofen is contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inf …

  Source SmPC ↗
• +BlockageContraindicated

  … oedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory (NSAID) drugs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (see section 4.4). Use in last trimester of pregnancy (see section 4.6 Fertility, Pregnancy and Lactation …

  Source SmPC ↗
• +PregnancyContraindicated

  … of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (see section 4.4). Use in last trimester of pregnancy (see section 4.6 Fertility, Pregnancy and Lactation).

  Source SmPC ↗
• +Kidney conditionsContraindicated

  … gs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Patients with severe hepatic failure, renal failure or severe heart failure (NYHA Class IV) (see section 4.4). Use in last trimester of pregnancy (see section 4.6 Fertility, Pregnancy and Lactation).

  Source SmPC ↗
• +Breathing conditionsContraindicated

  Hypersensitivity to ibuprofen or of any of the constituents in the product (see Section 4.4 Special Warnings and Precautions). Ibuprofen is contraindicated in patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non-steroidal anti-inflammatory (NSAID) drugs. Active or previous peptic ulcer (two or more distinct episodes of proven ulceration or bleeding). History of upper gastrointestinal bleeding or perforation, related to previous NSAIDs therapy. Pat …

  Source SmPC ↗
• +Benzyl alcoholWarning

  … ccount in patients with diabetes mellitus. There is a risk of renal impairment in dehydrated children and adolescents, between the ages of 12-18 year olds. Keep out of sight and reach of children. Propylparahydroxybenzoate and methylparahydroxybenzoate may cause allergic reactions (possibly delayed). The label will include: 12-18 years: if symptoms worsen, or persist for more than 3 days, or you get new symptoms consult your doctor. Adults: if symptoms worsen, or persist for more than 10 day …

  Source SmPC ↗
• +Taken with other medicinesWarning

  … um effective dose for the shortest possible duration to control symptoms (see GI and cardiovascular risks below). The elderly are at increased risk of the serious consequences of adverse reactions. Caution should be exercised when initiating treatment with ibuprofen in children with considerable dehydration. There is a risk of renal impairment in dehydrated children. Bronchospasms may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease. Use with concomitant NSAIDs including cyclo-oxygenase-2 specific inh …

  Source SmPC ↗
• +DehydrationWarning

  … um effective dose for the shortest possible duration to control symptoms (see GI and cardiovascular risks below). The elderly are at increased risk of the serious consequences of adverse reactions. Caution should be exercised when initiating treatment with ibuprofen in children with considerable dehydration. There is a risk of renal impairment in dehydrated children. Bronchospasms may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease. Use with concomitant NSAIDs including cyclo-oxygenase-2 specific inh …

  Source SmPC ↗
• +Older peopleWarning

  … n (see section 4.3 and 4.8). Undesirable effects may be minimised by using the minimum effective dose for the shortest possible duration to control symptoms (see GI and cardiovascular risks below). The elderly are at increased risk of the serious consequences of adverse reactions. Caution should be exercised when initiating treatment with ibuprofen in children with considerable dehydration. There is a risk of renal impairment in dehydrated children. Bronchospasms may be prec …

  Source SmPC ↗
• +Salt and mineral balanceWarning

  … ypertension and/or cardiac impairment as renal function may deteriorate and/or fluid retention occur (see section 4.5). Renal impairment as renal function may deteriorate (see section 4.3 and 4.8). Renal tubular acidosis and hypokalaemia may occur following acute overdose and in patients taking ibuprofen products over long periods at high doses (typically greater than 4 weeks), including doses exceeding the recommended daily dose. Hepatic dysfunction (see section 4.3 and 4.8). Undesirable effects may be minimised by using the minimum effective dose for the shortest possible duration to control symptoms (see GI and cardiovas …

  Source SmPC ↗
• +Intolerance to an ingredientWarning

  … ts is administered for fever or pain relief in relation to infection, monitoring of infection is advised. In non-hospital settings, the patient should consult a doctor if symptoms persist or worsen. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine as this product contains sucrose. Each tablet contains 67mg of sucrose. This should be taken into account in patients with diabetes mellitus. There is a risk of renal impairment in dehydrated children and adolescents, between the ages of 12-18 year olds. Keep out of sight and reach of children. Propylparahydroxybenzoate and methylparahy …

  Source SmPC ↗
• +FertilityWarning

  … me has been defined as cardiovascular symptoms secondary to an allergic or hypersensitive reaction associated with constriction of coronary arteries and potentially leading to myocardial infarction. There is some evidence that drugs which inhibit cyclo-oxygenase/prostaglandin synthesis may cause impairment of female fertility by an effect on ovulation. This is reversible on withdrawal of treatment. GI bleeding, ulceration or perforation, which can be fatal, has been reported with all NSAIDs at any time during treatment, with or without warning symptoms or a previous history of serious GI event …

  Source SmPC ↗
• +InfectionWarning

  Caution is required in patients with certain conditions: Systemic lupus erythematosus as well as those with mixed connective tissue disease due to increased risk of aseptic meningitis (see section 4.8). Gastrointestinal disorders and chronic inflammatory intestinal disease as these conditions may be exacerbated (ulcerative colitis, Crohn's disease) (see section 4.8). Caution is required prior to s …

  Source SmPC ↗
• +LactoseWarning

  … ts is administered for fever or pain relief in relation to infection, monitoring of infection is advised. In non-hospital settings, the patient should consult a doctor if symptoms persist or worsen. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine as this product contains sucrose. Each tablet contains 67mg of sucrose. This should be taken into account in patients with diabetes mellitus. There is a risk of renal impairment in dehydrated children and adolescents, between the ages of 12-18 year olds. Keep out of sight and reach of children. Propylparahydroxybenzoate and methylparahy …

  Source SmPC ↗
• +Acid build-up in the bloodWarning

  … ypertension and/or cardiac impairment as renal function may deteriorate and/or fluid retention occur (see section 4.5). Renal impairment as renal function may deteriorate (see section 4.3 and 4.8). Renal tubular acidosis and hypokalaemia may occur following acute overdose and in patients taking ibuprofen products over long periods at high doses (typically greater than 4 weeks), including doses exceeding the recommended daily dose. Hepatic dysfunction (see section 4.3 and 4.8). Undesirable effects may be minimised by using the minimum effective dose for the shortest possible duration to control symptoms (see GI and cardiovas …

  Source SmPC ↗
• +ChildrenWarning

  … um effective dose for the shortest possible duration to control symptoms (see GI and cardiovascular risks below). The elderly are at increased risk of the serious consequences of adverse reactions. Caution should be exercised when initiating treatment with ibuprofen in children with considerable dehydration. There is a risk of renal impairment in dehydrated children. Bronchospasms may be precipitated in patients suffering from or with a previous history of bronchial asthma or allergic disease. Use with concomitant NSAIDs including cyclo-oxygenase-2 specific inh …

  Source SmPC ↗
• +Serotonin effectsWarning

  … available. Patients with a history of GI toxicity, particularly the elderly, should report any unusual abdominal symptoms (especially GI bleeding) particularly in the initial stages of treatment. Caution should be advised in patients receiving concomitant medications, which could increase the risk of gastrotoxicity or bleeding, such as corticosteroids, or anticoagulants such as warfarin, selective serotonin re-uptake inhibitors or anti-platelet agents such as aspirin (see section 4.5). Where GI bleeding or ulceration occurs in patients receiving ibuprofen, the treatment should be withdrawn immediately. Severe cutaneous adverse reactions (SCARs): Severe cutaneous adverse reactions …

  Source SmPC ↗
• +Blood clotsWarning

  … previous history of bronchial asthma or allergic disease. Use with concomitant NSAIDs including cyclo-oxygenase-2 specific inhibitors (See section 4.5). Cardiovascular and cerebrovascular effects Clinical studies suggest that use of ibuprofen, particularly at high doses (2400mg/day) may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. ≤1200mg daily) is associated with an increased risk of arterial thrombotic events. Patients with uncontrolled hypertension, congestive heart failure (NYHA II-III), established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treat …

  Source SmPC ↗
• +UnclassifiedWarning

  Caution is required in patients with certain conditions: Systemic lupus erythematosus as well as those with mixed connective tissue disease due to increased risk of aseptic meningitis (see section 4.8). Gastrointestinal disorders and chronic inflammatory …

  Source SmPC ↗
• +Blood vessel conditionsWarning

  … ple myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low dose ibuprofen (e.g. ≤1200mg daily) is associated with an increased risk of arterial thrombotic events. Patients with uncontrolled hypertension, congestive heart failure (NYHA II-III), established ischaemic heart disease, peripheral arterial disease, and/or cerebrovascular disease should only be treated with ibuprofen after careful consideration and high doses (2400 mg/day) should be avoided. Careful consideration should also be exercised before initiating long-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, …

  Source SmPC ↗
• +BreastfeedingPregnancy

  … uterine contractions resulting in delayed or prolonged labour. Consequently, Anadin Joint Pain 200mg tablets is contraindicated during the third trimester of pregnancy (see sections 4.3 and 5.3). Lactation: In limited studies, ibuprofen appears in the breast milk in very low concentrations, and is unlikely to affect the breast fed infant adversely. See section 4.4 regarding female fertility.

  Source SmPC ↗
• +Alcohol—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Obstructed blood flow from the heart—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Hormone disorders—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Enzyme deficiency—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Heart rhythm block—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Sodium and potassium content—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Eye conditions—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Sugar alcohols—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Porphyria—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Propylene glycol—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Heart rhythm (QT interval)—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Shock—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Thyroid—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.

• +Gap needed after another medicine—Not in scanned sections

  Not found in the sections read for this label. Not the same as the label being silent.